Lisheng Chu
Impact in
- Neurology top 2%
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological Disease Mechanisms and Treatments
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
Papers in
- Neurology 17
- Neuroinflammation and Neurodegeneration Mechanisms 17
- Neurological Disease Mechanisms and Treatments 5
-
- S100 Proteins and Annexins 3
- Co-authors
- Yudong Zhou (9 shared papers)Guoliang Yu (7 shared papers)Xiaowei Hu (9 shared papers)San‐Hua Fang (8 shared papers)Mengling Wang (7 shared papers)Yan Fang (12 shared papers)Lin Li (7 shared papers)Er-Qing Wei (7 shared papers)
- Journals
- Acta Pharmacologica Sinica (3 papers)International Immunopharmacology (3 papers)Stem Cell Research & Therapy (2 papers)Life Sciences (2 papers)CNS Neuroscience & Therapeutics (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Lisheng Chu
39 papers receiving 1.2k citations
Lisheng Chu's Hit Papers
Peers
Comparison fields: 5 of 97
- Neurology 388
- Biological Psychiatry 48
- Developmental Neuroscience 54
- Complementary and alternative medicine 92
- Cancer Research 110
Countries citing papers authored by Lisheng Chu
This map shows the geographic impact of Lisheng Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisheng Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisheng Chu more than expected).
Fields of papers citing papers by Lisheng Chu
This network shows the impact of papers produced by Lisheng Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisheng Chu. The network helps show where Lisheng Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lisheng Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Quercetin improves cerebral ischemia/reperfusion injury by promoting microglia/macrophages M2 polarization via regulating PI3K/Akt/NF-κB signaling pathway Hit paper breakdown → | 2023 | 147 |
| 2 | 2021 | 113 | |
| 3 | 2004 | 97 | |
| 4 | 2006 | 88 | |
| 5 | 2022 | 74 | |
| 6 | 2017 | 65 | |
| 7 | 2005 | 64 | |
| 8 | 2007 | 63 | |
| 9 | 2006 | 62 | |
| 10 | 2006 | 62 | |
| 11 | 2006 | 37 | |
| 12 | 2019 | 35 | |
| 13 | 2009 | 35 | |
| 14 | 2006 | 32 | |
| 15 | 2022 | 27 | |
| 16 | 2017 | 26 | |
| 17 | 2023 | 21 | |
| 18 | 2024 | 21 | |
| 19 | 2018 | 19 | |
| 20 | 2009 | 17 |
About Lisheng Chu
Lisheng Chu is a scholar working on Neurology, Molecular Biology, Immunology, Cellular and Molecular Neuroscience and Developmental Neuroscience, having authored 44 papers that have together received 1.2k indexed citations. Recurring topics across this work include Neuroinflammation and Neurodegeneration Mechanisms (17 papers), Neurogenesis and neuroplasticity mechanisms (5 papers), Neurological Disease Mechanisms and Treatments (5 papers), Immune cells in cancer (4 papers), Mesenchymal stem cell research (4 papers), S100 Proteins and Annexins (3 papers), MicroRNA in disease regulation (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). The work is most often cited by research in Neurology (388 citations), Biological Psychiatry (48 citations), Developmental Neuroscience (54 citations), Complementary and alternative medicine (92 citations) and Cancer Research (110 citations). Lisheng Chu has collaborated with scholars based in China and United States. Frequent co-authors include Yudong Zhou, Guoliang Yu, Xiaowei Hu, San‐Hua Fang, Mengling Wang, Yan Fang, Lin Li, Er-Qing Wei, Yan Yang and Jingjing Gu. Their work appears in journals such as Acta Pharmacologica Sinica, International Immunopharmacology, Stem Cell Research & Therapy, Life Sciences and CNS Neuroscience & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.